Barclays PLC bought a new stake in Cronos Group Inc. (NASDAQ:CRON – Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 44,345 shares of the company’s stock, valued at approximately $97,000.
Several other large investors also recently made changes to their positions in CRON. Mackenzie Financial Corp acquired a new stake in shares of Cronos Group in the 2nd quarter valued at about $3,237,000. Dimensional Fund Advisors LP grew its stake in shares of Cronos Group by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,631,783 shares of the company’s stock valued at $6,132,000 after buying an additional 192,469 shares during the period. Intact Investment Management Inc. grew its stake in shares of Cronos Group by 89.1% in the 3rd quarter. Intact Investment Management Inc. now owns 377,890 shares of the company’s stock valued at $836,000 after buying an additional 178,100 shares during the period. Renaissance Technologies LLC grew its stake in shares of Cronos Group by 37.9% in the 2nd quarter. Renaissance Technologies LLC now owns 464,949 shares of the company’s stock valued at $1,083,000 after buying an additional 127,753 shares during the period. Finally, Public Employees Retirement System of Ohio acquired a new stake in shares of Cronos Group in the 3rd quarter valued at about $140,000. 8.71% of the stock is currently owned by institutional investors and hedge funds.
Cronos Group Price Performance
Shares of CRON opened at $1.93 on Friday. Cronos Group Inc. has a one year low of $1.86 and a one year high of $3.14. The company has a market cap of $737.84 million, a PE ratio of -14.85, a P/E/G ratio of 1.75 and a beta of 0.97. The stock has a 50-day moving average of $2.01 and a 200-day moving average of $2.16.
Cronos Group Company Profile
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
- Five stocks we like better than Cronos Group
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Bank Stocks – Best Bank Stocks to Invest In
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What Investors Need to Know to Beat the Market
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Want to see what other hedge funds are holding CRON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cronos Group Inc. (NASDAQ:CRON – Free Report).
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.